GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Ion Beam Applications IBAB.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

16.02

-2.08%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Ion Beam Applications

Its shares trade on Euronext Brussels under the ticker IBAB.BR. It has been listed since 13 June 1998. In the fiscal year to 31 December 2025, it reported revenue of €620.2m and net income of €12.7m. At that date it held total assets of €690.6m and shareholders' equity of €127.2m.

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
13 Jun 1998
Employees
1,251

Leadership

Pay as last reported

  • Mr. Pierre MottetChairman of the Board, Representing Saint-Denis SA, since 1988€77,250
  • Mr. Olivier LegrainChief Executive Officer, Managing Director and Internal Director, Representative of Lamaris Group SRL€841,682
  • Mr. Henri De RomreeDeputy Chief Executive Officer, Member of the Management Board
  • Ms. Catherine VandenborreChief Financial Officer, Head - IBA Corporate Entity
  • Mr. Yves JongenChief Research Officer, Managing Director, Internal Director, Representing Exoplanets Research SRL, since 1986€647,561
  • Ms. Muriel De LathouwerIndependent Director, Representing Much SRL€24,550
  • Mrs. Christine DubusIndependent Director, Representing Nextstepefficiency€89,740
  • Dr. Richard HausmannIndependent Director, Representing Hausmann Consulting€46,400
  • Dr. Hedvig HricakIndependent Director€32,000
  • Mr. Marcel MillerIndependent Director, Representing Consultance Marcel Miller SCS€46,400
  • Ms. Sybille Van Den HoveIndependent Director, Representing Bridging for Sustainability SPRL€35,600
  • Mr. Thomas PevenageIR Contact Officer, since 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
86
Environment
87
Social
97
Governance
74
Direct emissions (scope 1)
2,278 t
Energy emissions (scope 2)
686 t
Value chain emissions (scope 3)
144,976 t
Women in the workforce
27%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • High expertise in the field of ion beam technology, allowing for advanced and precise applications.
  • Strong reputation and long-standing presence in the industry, enhancing brand recognition and customer trust.
  • Wide range of products and services, catering to various industries and offering diverse solutions.

Weaknesses

  • Relatively high cost of ion beam technology compared to alternative methods, potentially limiting market penetration.
  • Dependency on specialized equipment and infrastructure, which may lead to increased operational complexities.
  • Limited geographical presence, restricting access to certain markets and potential customers.

Opportunities

  • Growing demand for ion beam applications in various sectors, such as semiconductor manufacturing and healthcare, providing opportunities for market expansion.
  • Increasing adoption of advanced technologies, creating potential partnerships and collaborations for joint research and development.
  • Emerging markets with untapped potential, offering opportunities for geographic diversification and business growth.

Threats

  • Intense competition from alternative technologies and methods, posing a threat to market share and pricing.
  • Economic downturns and fluctuations in market conditions, potentially impacting customer spending and investment in ion beam applications.
  • Regulatory challenges and compliance requirements, potentially hindering product development and commercialization.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.